ARLINGTON, Tenn.--(BUSINESS WIRE)--Wright Medical Group, Inc. (NASDAQ: WMGI), a global orthopaedic medical device company, announced that peer-reviewed data from a prospective, randomized, controlled, multi-center study has been published online and will appear in the June 2009 issue of the International Wound Journal. The data confirms the effectiveness of the Company’s GRAFTJACKET® Regenerative Matrix for the treatment of diabetic foot ulcers.
